4.7 Review

Pterocarpan scaffold: A natural lead molecule with diverse pharmacological properties

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 128, Issue -, Pages 219-236

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2017.01.023

Keywords

Pterocarpan; Natural product chemistry; Pharmacological activity

Funding

  1. NIMHD/NIH [2G12MD007605]
  2. Texas Southern University
  3. Karpagam University

Ask authors/readers for more resources

Phytoalexins are substances produced by plants that act as potent inhibitors of pathogens. Pterocarpans are biologically active isoflavonoids most commonly found in the family Fabaceae that have the ability to act as phytoalexins. It is made up of a tetracyclic ring system possessing benzofuran-benzopyran. A very great number of pterocarpans have been isolated from natural sources and they are proved to have significant biological activities such as anti-microbial, anti-cancerous, anti-inflammatory and antimalarial activities. Recently, pterocarpans gained lot of attention because of the broad range of anticancer activities in various cancer cell lines such as breast, leukemia, cervical, lung, colon and melanoma. Interestingly, pterocarpans exhibited inhibitory potency against many enzymes such as PTP1B, Neuraminidase, and alpha-glycosidase. In addition, they were shown to have anti-estrogenic and antidiabetic activities. This review is a comprehensive inventory of the structures and sources of pterocarpans and it emphasizes on the biological evaluations of pterocarpans from various plant sources and their scope as a lead molecule.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Compounds from diverse natural origin against triple-negative breast cancer: A comprehensive review

Ramasamy Thilagavathi, Sridhar Priyankha, Manivel Kannan, Muthuramalingam Prakash, Chelliah Selvam

Summary: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease caused by genetic mutations or overexpression. Chemotherapy and immunotherapy are common treatments, but the response rates are still low. Natural compounds derived from plants show promising inhibitory effects on TNBC, with advantages such as low toxicity and easy accessibility, making them important for the development of effective anti-tumor therapies.

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Article Chemistry, Physical

In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease

Kandhan Palanisamy, K. Rudharachari Maiyelvaganan, Shanmugasundaram Kamalakannan, Ramasamy Thilagavathi, Chelliah Selvam, Muthuramalingam Prakash

Summary: This study identified several compounds as potential drug targets for inhibiting SARS-CoV-2-related diseases, and these compounds exhibited potential drug-like properties and stability. Among them, asarinin was found to be the most effective inhibitor and may serve as a potent antiviral agent.

MOLECULAR SIMULATION (2023)

Article Biochemistry & Molecular Biology

Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening

S. M. Esther Rubavathy, Kandhan Palanisamy, S. Priyankha, Ramasamy Thilagavathi, Muthuramalingam Prakash, Chelliah Selvam

Summary: In this study, HDAC8 inhibitors with high affinity and good ADMET characteristics were screened from a natural product database. Through molecular docking, molecular dynamics, and MM-PBSA analysis, it was found that these compounds have strong binding affinity and are more effective than romidepsin. These findings may contribute to further development of HDAC8 inhibitors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Environmental Sciences

Antioxidant, anticancer, and toxicological evaluation of semi-synthetic curcumin benzothiazole analogue

Manivel Kannan, Ramasamy Thilagavathi, Chelliah Selvam

Summary: This study synthesized a curcumin benzothiazole analogue and evaluated its antioxidant properties, in vitro anticancer activity, and in vivo toxicity. The results showed that the analogue exhibited strong antioxidant activity and the highest cytotoxic activity against MDA MB 231 breast cancer cells. The substance was found to be safe up to levels of 300 mg/kg in albino wistar rats.

TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES (2023)

Article Biochemistry & Molecular Biology

Identification of indole-based natural compounds as inhibitors of PARP-1 against triple-negative breast cancer: a computational study

Sridhar Priyankha, Varatharaj Rajapandian, Kandhan Palanisamy, S. M. Esther Rubavathy, Ramasamy Thilagavathi, Chelliah Selvam, Muthuramalingam Prakash

Summary: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease caused by missing certain receptors. In this study, researchers screened natural products and identified six hit compounds with strong binding affinity towards the protein PARP-1, which is involved in the development of TNBC. Molecular dynamics simulations and calculations showed that two of these compounds had stronger binding energies with PARP-1 than an FDA-approved PARPi. The study offers valuable insights for the potential use of PARPi in TNBC treatment, and the findings were validated through comparison with an FDA-approved PARPi.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Review Pharmacology & Pharmacy

Nano formulation approaches for curcumin delivery- a review

Kumararaja Gayathri, Mahendran Bhaskaran, Chelliah Selvam, Ramasamy Thilagavathi

Summary: Curcumin, derived from the rhizomes of Curcuma longa Linn, has been extensively studied for its potential in treating various diseases. However, its inadequate intake and low aqueous solubility have posed challenges. To overcome these challenges, nanotechnology has been used to improve the absorption, solubility, and bioavailability of curcumin. Nano formulations of curcumin have shown promise in overcoming the limitations of traditional curcumin-based medications.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2023)

Review Chemistry, Medicinal

Recent insights into the hepatoprotective potential of medicinal plants and plant-derived compounds

Ramasamy Thilagavathi, S. Sameema Begum, Sowfika Dharshini Varatharaj, Arun Kumar Balasubramaniam, Joselin Susan George, Chelliah Selvam

Summary: Liver problems are a global concern and conventional therapies are ineffective. Protecting the liver is crucial for good health. Infections, immune issues, cancer, alcohol abuse, and drug overdose can cause liver diseases. Antioxidants from plants and dietary sources can protect the liver from oxidative stress and chemicals. Plant-derived compounds such as flavonoids, alkaloids, terpenoids, polyphenolics, sterols, anthocyanins, and saponin glycosides show hepatoprotective potential. More research is needed to develop safer and more potent phytochemical drugs for treating liver diseases.

PHYTOTHERAPY RESEARCH (2023)

Article Chemistry, Multidisciplinary

Structure-Based Drug Design: Identification of Glucokinase Activators from Natural Compounds for the Treatment of Type 2 Diabetes

Manokaran Malini, Ramasamy Thilagavathi, Sanjeev Kumar Singh, Arun Pravin, Chelliah Selvam

Summary: Glucokinase Activators (GKA) are small molecules that can bind to GK allosterically and effectively reduce plasma blood glucose levels, making them a potential therapeutic target for treating type 2 diabetes (T2D). In this study, a structure-based virtual screening was conducted on compounds from the Universal Natural Product Database (UNPD), resulting in the identification of four potential GKA small molecules. These compounds were found to interact strongly with specific active site residues of GK and satisfy drug-likeness criteria. Molecular dynamics simulation further confirmed the stability of the enzyme-small molecule complexes. Overall, this study provides valuable insights for identifying novel small molecules as GKAs.

CHEMISTRYSELECT (2023)

Article Chemistry, Physical

Identification of small-molecule glucokinase activator for type-2-diabetes treatment: a structure-based virtual screening approach

Manokaran Malini, Ramasamy Thilagavathi, Jannet Vennila, Beutline Malgija, Gandhi Praveena, Chelliah Selvam

Summary: This study used Fast Rigid Exhaustive Docking (FRED) method to screen compounds from the Zinc database with potential for activating insulin secretion. Molecular dynamics simulation and calculation found that these compounds have good stability and potential, and may become new glucokinase activators.

MOLECULAR SIMULATION (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)